Cumberland Pharmaceuticals Inc. (CPIX) financial statements (2022 and earlier)

Company profile

Business Address 2525 WEST END AVENUE
NASHVILLE,, TN 37203
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments27,04124,75428,21336,23050,08550,13252,767
Cash and cash equivalents27,04124,75428,21327,93945,41334,51038,203
Short-term investments   8,2914,67215,62214,564
Receivables6,87712,3789,7817,8448,3957,3306,077
Inventory, net of allowances, customer advances and progress billings8,43010,6389,41212,0786,7385,3724,270
Inventory8,43010,6389,41212,0786,7385,3724,270
Deferred tax assets   2,529
Other undisclosed current assets3,3402,2002,7572,9643,4672,7111,469
Total current assets:45,68849,97050,16359,11668,68565,54567,112
Noncurrent Assets
Inventory, Noncurrent9,049      
Operating lease, right-of-use asset1,0242,028 
Property, plant and equipment443574748771529464536
Intangible assets, net (including goodwill)24,83629,00031,80234,43921,44522,15421,169
Goodwill882882882784   
Intangible assets, net (excluding goodwill)23,95428,11830,92033,65521,44522,15421,169
Deferred costs 2,9003,1002,300   
Other noncurrent assets3,4203,2343,2992,5312,4872,1211,891
Deferred tax assets, net2287873,1201,211
Other undisclosed noncurrent assets 8,75715,41613,449   
Total noncurrent assets:38,77246,49454,38653,57824,54727,85924,807
TOTAL ASSETS:84,46096,463104,549112,69493,23293,40591,919
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities18,30924,65123,23027,80417,69514,79212,412
Accounts payable9,64113,39611,91211,0938,9808,0372,877
Accrued liabilities8,66811,25411,31716,7118,7156,7569,534
Other undisclosed current liabilities9701,017920    
Total current liabilities:19,27925,66724,15027,80417,69514,79212,412
Noncurrent Liabilities
Long-term debt and lease obligation15,09016,06018,50020,0009,8004,1001,700
Long-term debt, excluding current maturities15,00015,00018,50020,0009,8004,1001,700
Operating lease, liability901,060 
Liabilities, other than long-term debt7,4897,8638,7379,3191,8161,391987
Other liabilities7,4897,8638,7379,3191,8161,391987
Other undisclosed noncurrent liabilities  2,076    
Total noncurrent liabilities:22,57923,92229,31429,31911,6165,4912,687
Total liabilities:41,85849,59053,46457,12329,31120,28415,099
Stockholders' equity
Stockholders' equity attributable to parent, including:42,81446,99151,12355,84564,12073,24876,888
Retained earnings (accumulated deficit)(5,639)(2,131)1,2084,74611,70918,60519,550
Other undisclosed stockholders' equity attributable to parent48,45349,12249,91451,09952,41154,64357,338
Stockholders' equity attributable to noncontrolling interest(212)(117)(38)(274)(199)(127)(68)
Total stockholders' equity:42,60246,87351,08555,57163,92273,12176,820
TOTAL LIABILITIES AND EQUITY:84,46096,463104,549112,69493,23293,40591,919

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues35,98537,44147,53440,7421,6002,000900
Revenue, net41,15033,02633,519
Cost of revenue
(Cost of Goods and Services Sold)
(8,811)(8,653)(8,752)(7,378)(7,371)(5,959)(4,968)
Gross profit:27,17428,78838,78233,364(5,771)(3,959)(4,068)
Operating expenses(34,851)(35,170)(42,405)(40,754)(37,861)(28,500)(27,439)
Other undisclosed operating income    39,55031,02632,619
Operating income (loss):(7,677)(6,382)(3,623)(7,391)(4,081)(1,433)1,112
Nonoperating income
(Investment Income, Nonoperating)
2675243564299205209
Interest and debt expense(98)(264)(246)(196)(93)(106)(74)
Income (loss) from continuing operations before equity method investments, income taxes:(7,749)(6,570)(3,626)(7,022)(3,875)(1,335)1,247
Other undisclosed income from continuing operations before income taxes2,187      
Income (loss) from continuing operations before income taxes:(5,562)(6,570)(3,626)(7,022)(3,875)(1,335)1,247
Income tax expense (benefit)(35)(56)79(17)(4,175)331(576)
Income (loss) from continuing operations:(5,597)(6,626)(3,547)(7,039)(8,050)(1,004)671
Income from discontinued operations1,9943,207     
Net income (loss):(3,603)(3,419)(3,547)(7,039)(8,050)(1,004)671
Net income attributable to noncontrolling interest9579976715960
Net income (loss) available to common stockholders, diluted:(3,508)(3,339)(3,538)(6,963)(7,979)(945)731

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(3,603)(3,419)(3,547)(7,039)(8,050)(1,004)671
Other undisclosed comprehensive income  976715960
Comprehensive income (loss):(3,603)(3,419)(3,538)(6,963)(7,979)(945)731
Comprehensive income, net of tax, attributable to noncontrolling interest957918151142119120
Other undisclosed comprehensive loss, net of tax, attributable to parent  (26)(227)(214)(178)(181)
Comprehensive income (loss), net of tax, attributable to parent:(3,508)(3,339)(3,547)(7,039)(8,050)(1,004)671

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: